Page last updated: 2024-08-16

suramin and nf 279

suramin has been researched along with nf 279 in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (7.69)18.2507
2000's7 (53.85)29.6817
2010's5 (38.46)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ardanuy, U; Czeche, S; Damer, S; Lambrecht, G; Mutschler, E; Nickel, P; Niebel, B; Rettinger, J; Schmalzing, G1
Büttner, C; Klapperstück, M; Lambrecht, G; Markwardt, F; Nickel, P; Schmalzing, G1
Damer, S; Lambrecht, G; Müller, G; Nickel, P; Rettinger, J; Schmalzing, G1
Braun, K; Ganso, M; Hildebrandt, C; Kassack, M; Lambrecht, G; Nickel, P; Rettinger, J; Schmalzing, G; Ullmann, H1
Rettinger, J; Schmalzing, G1
Krishtal, O; Lalo, U; Pankratov, Y; Verkhratsky, A1
Cook, AK; Evans, RJ; Imig, JD; Inscho, EW; Vial, C1
Kauffenstein, G; Kukulski, F; Lavoie, EG; Lecka, J; Legendre, C; Lévesque, SA; Munkonda, MN; Pelletier, J; Sévigny, J1
Gordienko, DV; Harhun, MI; Povstyan, OV1
Searl, TJ; Silinsky, EM1
Giroud, C; Hammonds, J; Marin, M; Melikyan, GB; Spearman, P1
Anyanwu, AC; Burant, CF; Goonewardena, SN; Hyman, MC; Kanthi, Y; Petrovic-Djergovic, D; Pinsky, DJ; Rattan, R; Robichaud, P; Visovatti, SH; Wang, J1
Christensen, MG; Fagerberg, SK; Greve, AS; Johnsen, N; Praetorius, HA; Skals, M1

Other Studies

13 other study(ies) available for suramin and nf 279

ArticleYear
NF279: a novel potent and selective antagonist of P2X receptor-mediated responses.
    European journal of pharmacology, 1998, May-29, Volume: 350, Issue:1

    Topics: Adenosine Triphosphate; Animals; Colon; Guinea Pigs; In Vitro Techniques; Male; Oocytes; Purinergic P2 Receptor Antagonists; Rats; Suramin; Vas Deferens; Vasoconstriction; Xenopus laevis

1998
Antagonism by the suramin analogue NF279 on human P2X(1) and P2X(7) receptors.
    European journal of pharmacology, 2000, Jan-17, Volume: 387, Issue:3

    Topics: Animals; Female; Humans; Purinergic P2 Receptor Antagonists; Suramin; Xenopus laevis

2000
The suramin analogue NF279 is a novel and potent antagonist selective for the P2X(1) receptor.
    Neuropharmacology, 2000, Aug-23, Volume: 39, Issue:11

    Topics: Adenosine Triphosphate; Animals; Female; Humans; Purinergic Antagonists; Purinergic P2 Receptor Antagonists; Rats; Receptors, Purinergic; Receptors, Purinergic P2; Receptors, Purinergic P2X; Receptors, Purinergic P2X3; Receptors, Purinergic P2X4; Suramin; Xenopus laevis

2000
NF449: a subnanomolar potency antagonist at recombinant rat P2X1 receptors.
    Naunyn-Schmiedeberg's archives of pharmacology, 2001, Volume: 364, Issue:3

    Topics: Animals; Benzenesulfonates; Guinea Pigs; Ileum; Male; Muscle Contraction; Muscle, Smooth; Purinergic P2 Receptor Antagonists; Rats; Receptors, Purinergic P2X; Suramin; Vas Deferens; Xenopus laevis

2001
Desensitization masks nanomolar potency of ATP for the P2X1 receptor.
    The Journal of biological chemistry, 2004, Feb-20, Volume: 279, Issue:8

    Topics: Adenosine Triphosphate; Affinity Labels; Animals; Binding, Competitive; Dose-Response Relationship, Drug; Electrophysiology; Kinetics; Models, Biological; Models, Chemical; Oocytes; Plasmids; Protein Binding; Receptors, Purinergic P2; Receptors, Purinergic P2X; Recombinant Fusion Proteins; Suramin; Thionucleotides; Time Factors; Xenopus

2004
P2X receptor-mediated excitatory synaptic currents in somatosensory cortex.
    Molecular and cellular neurosciences, 2003, Volume: 24, Issue:3

    Topics: Adenosine Triphosphate; Animals; Electric Stimulation; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; GABA Antagonists; Nicotinic Antagonists; Organ Culture Techniques; Patch-Clamp Techniques; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Pyramidal Cells; Pyridoxal Phosphate; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2; Receptors, Purinergic P2X; Serotonin Antagonists; Somatosensory Cortex; Suramin; Synapses; Synaptic Transmission

2003
Physiological role for P2X1 receptors in renal microvascular autoregulatory behavior.
    The Journal of clinical investigation, 2003, Volume: 112, Issue:12

    Topics: Adenosine Triphosphate; Animals; Diuretics; Dose-Response Relationship, Drug; Furosemide; Gene Deletion; Kidney; Male; Mice; Mice, Knockout; Microcirculation; Perfusion; Pressure; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2; Receptors, Purinergic P2X; Renal Circulation; Suramin; Time Factors; Xanthines

2003
Inhibition of human and mouse plasma membrane bound NTPDases by P2 receptor antagonists.
    Biochemical pharmacology, 2007, Nov-15, Volume: 74, Issue:10

    Topics: Adenosine Diphosphate; Adenosine Triphosphatases; Adenosine Triphosphate; Animals; Antigens, CD; Aorta, Thoracic; Apyrase; Benzenesulfonates; Cell Membrane; Chlorocebus aethiops; COS Cells; Humans; Hydrolysis; Mice; Mice, Knockout; Purinergic P2 Receptor Antagonists; Recombinant Proteins; Suramin; Transfection; Triazines

2007
Purinoreceptor-mediated current in myocytes from renal resistance arteries.
    British journal of pharmacology, 2010, Volume: 160, Issue:4

    Topics: Adenosine Triphosphate; Animals; Arteries; Kidney; Kinetics; Male; Membrane Potentials; Microdissection; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Organ Specificity; Osmolar Concentration; Patch-Clamp Techniques; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Rats; Rats, Inbred WKY; Receptors, Purinergic P2; Receptors, Purinergic P2X; Receptors, Purinergic P2X4; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Suramin

2010
Modulation of purinergic neuromuscular transmission by phorbol dibutyrate is independent of protein kinase C in murine urinary bladder.
    The Journal of pharmacology and experimental therapeutics, 2012, Volume: 342, Issue:2

    Topics: Adenosine Triphosphate; Animals; Calcium Channel Blockers; Calcium Channels; Electric Stimulation; Membrane Potentials; Mice; Neuromuscular Junction; Neurotransmitter Agents; Phorbol 12,13-Dibutyrate; Phorbol Esters; Protein Kinase C; Protein Kinase Inhibitors; Purinergic Agents; Purinergic P2X Receptor Antagonists; Receptors, Purinergic; Sodium Channel Blockers; Sodium Channels; Suramin; Synaptic Transmission; Urinary Bladder

2012
P2X1 Receptor Antagonists Inhibit HIV-1 Fusion by Blocking Virus-Coreceptor Interactions.
    Journal of virology, 2015, Volume: 89, Issue:18

    Topics: CD4-Positive T-Lymphocytes; Female; HEK293 Cells; HIV-1; Humans; Male; Purinergic P2X Receptor Antagonists; Receptors, CCR5; Receptors, CXCR4; Receptors, Purinergic P2X1; Suramin; Virus Internalization

2015
Purinergic dysregulation in pulmonary hypertension.
    American journal of physiology. Heart and circulatory physiology, 2016, 07-01, Volume: 311, Issue:1

    Topics: Adenosine; Adenosine Triphosphate; Animals; Antigens, CD; Antihypertensive Agents; Apyrase; Arterial Pressure; Disease Models, Animal; Genetic Predisposition to Disease; Humans; Hydrolysis; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Lung; Mice, Inbred C57BL; Mice, Knockout; Phenotype; Pulmonary Artery; Purinergic P2X Receptor Antagonists; Receptors, Purinergic P2X1; Severity of Illness Index; Signal Transduction; Suramin; Vascular Remodeling; Ventricular Remodeling

2016
P2X
    Purinergic signalling, 2019, Volume: 15, Issue:2

    Topics: Animals; Benzenesulfonates; Blood Platelets; Escherichia coli Infections; Hemolysin Proteins; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Purinergic P2X Receptor Antagonists; Pyelonephritis; Receptors, Purinergic P2X1; Sepsis; Suramin; Urinary Tract Infections; Uropathogenic Escherichia coli

2019